All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Completed, but no date | 2004-000838-36 | A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer | bad-data | |
| Ongoing | 2005-000558-60 | A Phase II trial evaluating the immunological and clinical efficacy and safety of HER-2 Protein AutoVac(TM) and Stimulon® Adjuvant QS-21 monotherapy in patients with metastatic breast cancer | not-yet-due | |
| Listed as ongoing, but also has a completion date | 2005-005014-21 | “Primovax” – A Phase III Trial Comparing GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Advanced Un-resectable Pancreatic Cancer. | 2008-05-13 | bad-data |
| Listed as ongoing, but also has a completion date | 2006-002211-26 | Heptovax - A Phase II, Open-label trial evaluating the safety and efficacy of GV1001 in advanced hepatocellular carcinoma. | 2008-04-29 | bad-data |